Clinical Trials Logo
  1. Home
  2. Pregnancy
  3. NCT01917799
  4. Details
NCT01917799 Clinical Trial

Aspirin, Heparin and Miscarriage

Pregnancy Clinical Trial

Official title:
Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01917799
Other study ID # LDA and LMWH
Secondary ID
Status Recruiting
Phase Phase 4
First received July 31, 2013
Last updated August 6, 2013
Start date January 2009
Est. completion date December 2013

Study information
Verified date August 2013
Source University of Khartoum
Contact n/a
Is FDA regulated No
Health authority Libya:Misurata Central Hospital
Study type Interventional

Clinical Trial Summary

Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.

Recruitment information / eligibility
Status Recruiting
Enrollment 150
Est. completion date December 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Female
Age group 15 Years to 48 Years
Eligibility Inclusion Criteria:

- Pregnant women

- History of 2 or more of miscarriage

Exclusion Criteria:

- Twins

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• Aspirin
75mg tab of LDA once daily for 7 months
• Heparin
0.4 mL/day of the Enoxaparin

Locations
Country Name City State
Libyan Arab Jamahiriya Misurata Teaching Hospital Misurata

Sponsors (1)
Lead Sponsor Collaborator
University of Khartoum

Country where clinical trial is conducted

Libyan Arab Jamahiriya, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of miscarriages To compare number of miscarriages between the two groups 3 months No
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02528136 - The Clinical Carbetocin Myocardium Trial Phase 4